Skip to content

PMCF Study on the Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm in the Elbow

Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm Soft Tissue System (Implants and Instrumentation) in the Elbow - A Multicenter Retrospective Consecutive Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05519228
Enrollment
83
Registered
2022-08-29
Start date
2022-09-12
Completion date
2024-02-20
Last updated
2025-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biceps Tendon Disorder, Epicondylitis of the Elbow

Keywords

Post-Market Clinical Follow-Up Study, Medical Device, Performance, Safety, Clinical Benefits

Brief summary

The study is a multicenter, retrospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to collect data confirming safety, performance and clinical benefits of the ToggleLoc 2.9 mm Soft Tissue System when used for soft tissue to bone fixation in the elbow. The primary objective is the assessment of performance by analyzing soft tissue to bone healing in the elbow. The secondary objective is the assessment of safety and clinical benefits. Safety will be evaluated by recording and analyzing the incidence and frequency of complications and adverse events. Relation of the events to device, instrumentation and/or procedure will be specified. Clinical benefits will be assessed by recording patient-reported outcome measures (PROMs) at the longest follow-up after surgery (minimum one year).

Detailed description

The ToggleLoc 2.9 mm Soft Tissue System consist of non-resorbable device intended to aid in arthroscopic and orthopaedic reconstructive procedures requiring soft tissue to bone fixation. The clinical purpose is to restore the function and flexibility of the elbow requiring soft tissue to bone fixation and to relieve pain that cannot be controlled by other treatments. Two sites will be involved in this study. The aim is to include a total of 83 consecutive series cases operated with the ToggleLoc 2.9 mm in the elbow. All potential study subjects will be required to participate in the Informed Consent Process. Baseline data from the preop and intraop will be available in medical notes. The patients will be asked to complete patient questionnaires during a minimum 1 year follow up visit/phone call. In addition, any complications and adverse events that occured since the surgery will also be collected during the follow-up visit/phone call.

Interventions

DEVICEToggleLoc 2.9 mm Soft Tissue System

The ToggleLoc 2.9 mm Soft Tissue System consist of non-resorbable device intended to aid in arthroscopic and orthopaedic reconstructive procedures requiring soft tissue to bone fixation

Sponsors

Zimmer Biomet
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who received the ToggleLoc 2.9 mm Soft Tissue device for soft tissue to bone fixation in the elbow. * Patients 18 years or older and skeletally mature. * Patients capable of understanding the surgeon's explanations and following his/her instructions, able and willing to participate in the follow-up program and who gave consent to take part in the study.

Exclusion criteria

* Infection. * Patient conditions including blood supply limitations, and insufficient quantity or quality of bone or soft tissue. * Patients with mental or neurologic conditions who are unwilling or incapable of following postoperative care instructions. * Foreign body sensitivity. Where material sensitivity is suspected, testing is to be completed prior to implantation of the device. * Patients who have any condition that would in the judgment of the Investigator place the patient at undue risk or interfere with the study. * Patient is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, anticipated to be non-compliant). * Off-label use.

Design outcomes

Primary

MeasureTime frameDescription
Soft Tissue to Bone Healing in the Elbow - Hook TestFrom operation to the study completion, minimum 1 year post-op.Assessment of performance by analyzing soft tissue to bone healing in the elbow. The principal investigator will clinically evaluate the study elbow to assess if soft tissue to bone healing has occurred using the Hook test. The Hook test is performed by hooking the finger, that is inserted laterally under the biceps tendon, under the cord-like structure spanning the antecubital fossa with the patient's elbow flexed at 90 degrees. Each case that a Hook test was performed on will be counted as 1 count and will be described as 1 case if successful, meaning this case had successful soft tissue to bone healing.

Secondary

MeasureTime frameDescription
EuroQol Five-dimensional Health Questionnaire (EQ-5D-5L): Visual Analogue Scale (VAS)At minimum 1 year post-op.Assessment of patient-reported outcome measures (PROMs): The EuroQol fivedimensional Health Questionnaire (EQ-5D-5L) is a generic instrument. The EQ-5D-5L VAS is scored on a 0 to 100 mm scale. 0 mm represents the worst... and 100 mm represents the best health you can imagine.
EuroQol Five-dimensional Health Questionnaire (EQ-5D-5L): EQ-5D-5L ProfileAt minimum 1 year post-op.Assessment of patient-reported outcome measures (PROMs): The EuroQol fivedimensional Health Questionnaire (EQ-5D-5L) is a generic instrument. In the EQ-5D-5L Profile the highest score is 1 and the lowest score is -0.573; negative numbers correspond to a self-assessed health state worse than being dead.
Oxford Elbow Score (OES)At minimum 1 year post-op.Assessment of patient-reported outcome measures (PROMs): The Oxford Elbow Score (OES) consists of 12 questionnaire items with five original response options each and is specifically designed and developed for assessing outcomes of elbow surgery. The score will be on a scale from 0 (worst) to 48 (best).

Countries

Spain, United States

Participant flow

Participants by arm

ArmCount
Patients Suffering From Biceps Tendon Rupture
Patients in need of a ToggleLoc 2.9mm in the Elbow for biceps tendon reattachment
83
Total83

Baseline characteristics

CharacteristicPatients Suffering From Biceps Tendon Rupture
Age, Continuous46.3 years
STANDARD_DEVIATION 8.1
BMI29.0 kg/m2
STANDARD_DEVIATION 4.9
Height177.0 cm
STANDARD_DEVIATION 7.5
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
82 Participants
Weight91.8 kg
STANDARD_DEVIATION 19

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 83
other
Total, other adverse events
13 / 83
serious
Total, serious adverse events
1 / 83

Outcome results

Primary

Soft Tissue to Bone Healing in the Elbow - Hook Test

Assessment of performance by analyzing soft tissue to bone healing in the elbow. The principal investigator will clinically evaluate the study elbow to assess if soft tissue to bone healing has occurred using the Hook test. The Hook test is performed by hooking the finger, that is inserted laterally under the biceps tendon, under the cord-like structure spanning the antecubital fossa with the patient's elbow flexed at 90 degrees. Each case that a Hook test was performed on will be counted as 1 count and will be described as 1 case if successful, meaning this case had successful soft tissue to bone healing.

Time frame: From operation to the study completion, minimum 1 year post-op.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ToggleLoc 2.9 mm Soft Tissue DeviceSoft Tissue to Bone Healing in the Elbow - Hook Test83 Participants
Secondary

EuroQol Five-dimensional Health Questionnaire (EQ-5D-5L): EQ-5D-5L Profile

Assessment of patient-reported outcome measures (PROMs): The EuroQol fivedimensional Health Questionnaire (EQ-5D-5L) is a generic instrument. In the EQ-5D-5L Profile the highest score is 1 and the lowest score is -0.573; negative numbers correspond to a self-assessed health state worse than being dead.

Time frame: At minimum 1 year post-op.

ArmMeasureValue (MEAN)Dispersion
ToggleLoc 2.9 mm Soft Tissue DeviceEuroQol Five-dimensional Health Questionnaire (EQ-5D-5L): EQ-5D-5L Profile1.0 score on a scaleStandard Deviation 0.1
Secondary

EuroQol Five-dimensional Health Questionnaire (EQ-5D-5L): Visual Analogue Scale (VAS)

Assessment of patient-reported outcome measures (PROMs): The EuroQol fivedimensional Health Questionnaire (EQ-5D-5L) is a generic instrument. The EQ-5D-5L VAS is scored on a 0 to 100 mm scale. 0 mm represents the worst... and 100 mm represents the best health you can imagine.

Time frame: At minimum 1 year post-op.

ArmMeasureValue (MEAN)Dispersion
ToggleLoc 2.9 mm Soft Tissue DeviceEuroQol Five-dimensional Health Questionnaire (EQ-5D-5L): Visual Analogue Scale (VAS)83.3 score on a scaleStandard Deviation 14.9
Secondary

Oxford Elbow Score (OES)

Assessment of patient-reported outcome measures (PROMs): The Oxford Elbow Score (OES) consists of 12 questionnaire items with five original response options each and is specifically designed and developed for assessing outcomes of elbow surgery. The score will be on a scale from 0 (worst) to 48 (best).

Time frame: At minimum 1 year post-op.

ArmMeasureValue (MEAN)Dispersion
ToggleLoc 2.9 mm Soft Tissue DeviceOxford Elbow Score (OES)46.7 score on a scaleStandard Deviation 3.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026